Need for a Heat-Stable Measles Vaccine for Use in West and Central Africa

Bernard Guyer, A. Marshal McBean, Albert E. Henn

Research output: Contribution to journalLetterpeer-review

Abstract

To the Editor: During the five years of the Smallpox Eradication and Measles Control Program (SMP) in West and Central Africa (1967–1971), 20 million children were vaccinated against measles at an estimated cost of $18 million to the United States alone. Yet, despite the use of an efficacious, live attenuated vaccine (Schwarz), measles was not controlled and continues to be one of the major causes of childhood mortality in this part of Africa.

Original languageEnglish (US)
Number of pages1
JournalNew England Journal of Medicine
Volume292
Issue number10
DOIs
StatePublished - Mar 6 1975
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Need for a Heat-Stable Measles Vaccine for Use in West and Central Africa'. Together they form a unique fingerprint.

Cite this